The Risk of Long-term Morbidity and Mortality in Patients With Chronic Hepatitis C-Reference-Cited by-同舟云学术

The Risk of Long-term Morbidity and Mortality in Patients With Chronic Hepatitis C

Published:2014-02-01 Issue:2 Volume:174 Page:204
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

McCombs Jeffrey¹,Matsuda Tara²,Tonnu-Mihara Ivy³,Saab Sammy⁴,Hines Patricia⁵,L’Italien Gilbert⁵,Juday Timothy⁵,Yuan Yong⁵

Affiliation:

1. Department of Clinical Pharmacy and Pharmaceutical Economics and Policy, School of Pharmacy, Leonard Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles

2. Department of Clinical Pharmacy and Pharmaceutical Economics and Policy, School of Pharmacy, Leonard Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles2Veterans Affairs Long Beach Healthcare System, Long Beach

3. Veterans Affairs Long Beach Healthcare System, Long Beach, California

4. Departments of Medicine and Surgery, David Geffen School of Medicine, University of California, Los Angeles

5. Global Health Economics and Outcomes Research, Bristol-Myers Squibb, Plainsboro New Jersey

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computer-aided molecular modeling and design studies of some N-(4-(dimethyl amino) phenyl)-4-methoxy-3-propionamidobenzamide derivatives as NS5B polymerase inhibitors;The Microbe;2024-09

2. Unmet Needs in the Post–Direct-Acting Antiviral Era: Hepatocarcinogenesis After Hepatitis C Virus Eradication;The Journal of Infectious Diseases;2023-09-13

3. Direct-acting Antivirals for Hepatitis C and Implication for Community Pharmacy Practice;Current Pharmaceutical Design;2023-07

4. Geographical variation in hepatitis C-related severe liver disease and patient risk factors: a multicentre cross-sectional study;Epidemiology and Infection;2023

5. Direct‐acting antiviral therapy for chronic hepatitis C among incarcerated people who inject drugs;Advances in Digestive Medicine;2022-10-17